PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026BMJ Open0 citationsOpen Access

Risk factors for skin rash among patients with cancer receiving epidermal growth factor receptor inhibitors: a scoping review protocol

View Full Paper
LZLijuan ZhangLiaoning University of Traditional Chinese MedicineYZYazheng ZhaiLiaoning University of Traditional Chinese MedicineYWYanru WangLiaoning University of Traditional Chinese Medicine

Key Points

  • This review aims to identify and summarize risk factors associated with skin rash in cancer patients treated with epidermal growth factor receptor inhibitors.
  • Conduct a scoping review using published and publicly available sources
  • Analyze existing literature on risk factors for skin rash
  • Disseminate findings through various academic channels
  • Study does not present results yet as it is a protocol
  • Findings will inform clinical practices upon completion
  • Results may highlight specific demographic or treatment-related risk factors

Abstract

This scoping review will rely exclusively on the collection and analysis of published and/or publicly available sources; therefore, ethical approval is not required. The findings will be disseminated through publication in peer-reviewed journals, presentation at scientific conferences and via digital science communication platforms.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69d893eb6c1944d70ce04d69https://doi.org/10.1136/bmjopen-2025-103333
Ask AI
Helpful
Bookmark
Share
View Full Paper